MedTrace Logo

Myoglobin Removal With CytoSorb in Rhabdomyolysis

NCT06503289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2025-06-15

No results posted yet for this study

Summary

The aim of this observational study is to assess whether myoglobin removal with CytoSorb® ameliorates endothelial damage in severe rhabdomyolysis patients who are admitted to the intensive care unit. The primary objective of the study is:

\- Does myoglobin removal with CytoSorb® reduces glycocalyx degradation markers?

Patients with severe rhabdomyolysis will receive the intervention and blood samples will be obtained in regular intervals.

Conditions

Interventions

DEVICE

Cytosorb therapy

Extracorporeal treatment with cytosorb filter to patients diagnosed with rhabdomyolysis

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    lead OTHER

Principal Investigators

  • mustafa altınay · şişli etfal eğitim araştırma hastanesi

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-01-22
Completion
2025-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06503289 on ClinicalTrials.gov